TPST icon

Tempest Therapeutics
TPST

Overview Fund Activity

42 hedge funds and large institutions have $12.9M invested in Tempest Therapeutics in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 21 reducing their positions, and 14 closing their positions.

Holders
42
Holders Change
-9
Holders Change %
-17.65%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
21
Closed
14
Calls
$47K
Puts
$200K
Net Calls
-$153K
Net Calls Change
-$366K

Top Buyers

1
GTC
1
Ghost Tree Capital
New York
$1.51M
2
AFM
2
Anson Funds Management
Texas
$577K
3
WG
3
Winton Group
United Kingdom
$297K
4
Citadel Advisors
4
Citadel Advisors
Florida
$1.29M
5
SSA
5
Schonfeld Strategic Advisors
New York
$52K

Top Sellers

1
B
1
Bpifrance
France
$875K
2
GPP
2
Great Point Partners
Connecticut
$1.92M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$521K
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$0
5
HT
5
HAP Trading
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
51
Qube Research & Technologies (QRT)
United Kingdom
– -$19K -54 Closed
JG
52
Jefferies Group
New York
– -$12 -36 Closed
Deutsche Bank
53
Deutsche Bank
Germany
– -$5K -15 Closed
PFGIA
54
Patriot Financial Group Insurance Agency
Massachusetts
– -$4K -13 Closed
1 2
3